Zepbound Cost in Arkansas (2026)
Affordability Score™ · AR
Zepbound (tirzepatide) lists at $1,021/month in Arkansas. Weight-loss plans may require Zepbound (not Mounjaro) on the claim — savings programs can lower copays significantly.
Quick answer
Zepbound (tirzepatide) lists at $1,021/month in Arkansas (2026). With commercial insurance and a savings card, many patients pay $25–$94/month — use the calculator below for your estimate.
Arkansas market notes for Zepbound (tirzepatide)
For Zepbound (tirzepatide, obesity) in Arkansas, treat prior auth as an obesity-benefit review: BMI thresholds, lifestyle documentation, and specialty mail-order rules drive the true monthly cost more than the list price alone. Arkansas (AR) GLP-1 pricing follows national list prices adjusted by local pharmacy competition, employer formulary design, and whether Medicaid or Medicare Advantage dominates the insurance mix. Commercial plans in Arkansas commonly require prior authorization for obesity-indicated brands (Wegovy, Zepbound) while diabetes paths for Ozempic or Mounjaro clear more reliably when medically indicated. Manufacturer savings cards usually exclude government insurance—so Medicare, Medicaid, TRICARE, and VA patients in Arkansas need a separate model than the “$25/month” ads. Before you commit, get a written pharmacy quote for the exact NDC, confirm PA status with your insurer, and compare mail-order specialty copays against a local cash fill.
State cost index modifier: 0.94× · List ~$1,021/mo · Card path typically $25–$94/mo when eligible.
Free comparison
Compare GLP-1 options in Arkansas
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Affordability audit
Step 1 — Pick your medication
Affordability Score™ is an educational estimate — not medical, insurance, or pharmacy advice.
All GLP-1 prices — AR
| Medication | List/mo | With card | Cash programs |
|---|---|---|---|
| Ozempic (semaglutide) | $911 | $25 – $94 | $328 – $469 |
| Wegovy (semaglutide) | $1,268 | $25 – $94 | $328 – $469 |
| Mounjaro (tirzepatide) | $1,045 | $25 – $94 | $328 – $469 |
| Zepbound (tirzepatide) | $1,021 | $25 – $94 | $328 – $469 |
Other GLP-1 drugs in Arkansas
What affects Zepbound (tirzepatide) cost in Arkansas?
- Insurance type and whether your plan covers chronic weight management
- Prior authorization and BMI requirements
- Manufacturer savings card eligibility
- Arkansas regional cost index (modifier 0.94×)
- Compounded alternatives vs brand tirzepatide
Medicare & Medicaid — Arkansas
Wegovy/Zepbound for weight loss are generally not covered by Medicare Part D as of 2026.
Related pages
Frequently Asked Questions
How much does Zepbound (tirzepatide) cost in Arkansas without insurance?
List price in Arkansas is about $1,021/month. Cash discount programs may reduce cost to $328–$469/month; compounded tirzepatide runs $187–$375/month via telehealth.
Does insurance cover Zepbound (tirzepatide) in Arkansas?
Eli Lilly markets Zepbound for chronic weight management. Commercial plans often require prior authorization; Medicare coverage depends on indication. See our <a href="/guides/glp1-prior-authorization/" class="text-accent-400 underline">prior auth guide</a>.
What is the cheapest way to get Zepbound in Arkansas?
With insurance + manufacturer savings card, eligible patients often pay $25–$94/month. Run the <a href="/affordability-audit/" class="text-accent-400 underline">Affordability Audit</a> for your scenario.
How does Arkansas compare to other states for Zepbound cost?
Arkansas uses a regional cost modifier of 0.94× vs national average. See <a href="/glp1-state-rankings/" class="text-accent-400 underline">50-state Affordability Rankings</a>.
How We Estimate GLP-1 Costs
MetaDose estimates combine manufacturer list prices (Novo Nordisk, Eli Lilly), NovoCare/LillyDirect cash programs, and state pharmacy cost indices — updated 2026-07-15.
Updated 2026-07-15. Novo Nordisk list prices, Lilly list prices, NovoCare/LillyDirect cash programs, GoodRx averages. Educational estimates only.